We are dedicated to transforming rare disease health outcomes by building communities to support patients, advocates, carers and healthcare professionals. We empower our communities with access to the latest information and the ability to own and control their entire health record. We are already supporting over 50,000 patients globally.
Founded in 2022, AllMyHealth is headquartered in Scale Space, at the heart of the White City, London’s innovation district. We are backed by global venture builder Blenheim Chalcot, which has built 60+ innovative technology businesses over the last 25 years.
At AllMyHealth we believe that all patients should be empowered with the latest information about their diagnosis, treatment options and full health record.
Our technology empowers patients with rare diseases to connect and stay up-to-date with the latest news about their condition and to securely access, store and manage their entire health record. We provide them with the tools to share their records with whoever they choose, including medical professionals and researchers working on groundbreaking treatment discoveries or helping them access treatment funding.
In doing so, we put patients at the heart of medical innovation, accessing critical treatment and information sooner. We believe that the future of medical advancements lies in the power of patient-driven data sharing.
We adhere to stringent data security and privacy standards, ensuring that every piece of shared information is safeguarded. We’re committed to maintaining the utmost transparency and obtaining informed consent. We believe that trust, respect, and patient autonomy are fundamental in building a healthcare ecosystem that truly works for everyone. Visit our Trust Centre to learn more.
Sign up to our waitlist today to securely access and manage your entire health record. Together, we can transform health data into a powerful tool to improve care and advance the development of treatments for communities like yours.